Gotham Therapeutics Companies
Gotham Therapeutics is discovering a novel drug class targeting the epitranscriptomics machinery.The company offers treatment options for patients suffering from cancers, auto-immune and neurodegenerative diseases.
Industry:
AI for Longevity
Headquarters:
New York, New York, United States
Founded Date:
Jan 2017
Employees Number:
55 employees
Register and Claim Ownership